Latest News & Updates

Breaking News

9 minutes ago
Vaibhavi M.

Stanford Expert Says Hantavirus Cruise Outbreak Won't Cause Pandemic, But It's a Warning Sign

MV Hondius Hantavirus Passenger Update, Disembarkation Begins in Tenerife as Cases Rise

Vaibhavi M.

CDC Confirms Hantavirus Cruise Ship Outbreak, Reassures Americans Risk Remains "Extremely Low"

Vaibhavi M.

Zentalis Pharmaceuticals Advances Azenosertib Toward FDA Accelerated Approval With Pivotal Dose Selection

Pharma Now Editorial Team

Recordati Achieves Phase 2 Primary Endpoint for Pasireotide in Post-Bariatric Hypoglycemia Ahead of FDA Meeting

Pharma Now Editorial Team

Other trending news you may like to read

Stanford Expert Says Hantavirus Cruise Outbreak Won't Cause Pandemic, But It's a Warning Sign

Stanford's Dr Jorge Salinas says MV Hondius hantavirus poses near-zero public risk but calls the outbreak a warning sign of accelerating zoonotic disease driven by climate change.

Vaibhavi M.

MV Hondius Hantavirus Passenger Update, Disembarkation Begins in Tenerife as Cases Rise

MV Hondius passengers disembark in Tenerife via charter flights after hantavirus kills three; WHO Director-General attends in person as a French woman tests positive mid-flight home.

Vaibhavi M.

CDC Confirms Hantavirus Cruise Ship Outbreak, Reassures Americans Risk Remains "Extremely Low"

CDC confirms Andes virus outbreak aboard MV Hondius, activates contact tracing for U.S. passengers, and states overall risk to American public and travellers remains extremely low.

Vaibhavi M.

Zentalis Pharmaceuticals Advances Azenosertib Toward FDA Accelerated Approval With Pivotal Dose Selection

Zentalis selects pivotal dose for azenosertib and initiates Phase 3 confirmatory trial, targeting FDA accelerated approval in Cyclin E1-positive PROC.

Pharma Now Editorial Team